Gore Tex Implants in the Treatment of Atrophic Rhinitis

NCT ID: NCT00832403

Last Updated: 2009-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Total Enrollment

5 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrophic Rhinitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

atrophic rhinitis implants Polytetrafluoroethylene

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

polytetrafluoroethylene

implants of polytetrafluoroethylene in tha nasal fossa

Intervention Type OTHER

surgical implants of polytetrafluoroethylene in the nasal fossa

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

implants of polytetrafluoroethylene in tha nasal fossa

surgical implants of polytetrafluoroethylene in the nasal fossa

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria

* Patients with mental illness
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Felicio Rocho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hospital Felício Rocho

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Rinite Atrófica cep/hfr

Identifier Type: -

Identifier Source: org_study_id